The multidrug-resistant ST131-O25b clone of Escherichia coli is well established as a significant cause of extra-intestinal infections worldwide. However, there have been only two small regional studies comparing ST131 isolates from the UK. Therefore, we characterized 143 ST131 E. coli (38 urinary, 105 bloodstream) collected between January 2011 and March 2012 from 38 centres located across the UK and Republic of Ireland. Phenotypic and genotypic characterization of clonal isolates revealed high rates of resistance to amoxicillin-clavulanate (56 %), cefotaxime (32 %), ciprofloxacin (79 %), temocillin (69 %, bloodstream isolates only), gentamicin (67 %) and trimethoprim-sulfamethoxazole (59 %). The most frequently detected extended-spectrum beta-lactamase was CTX-M-15 (87 %), predominantly encoded on IncF plasmids, although it was also associated with IncU plasmids in two isolates. The majority of UK ST131 clonal isolates possessed the O25b antigen (97 %) and the H30 fimH allele (92 %), but three serogroups (O19a, O136 and O153) novel to ST131 were identified among our strains. Contrary to previous reports, UK ST131-O16 isolates were typically susceptible to ciprofloxacin and lacked beta-lactamase genes (n512/12). In summary, ST131 strains of E. coli circulating in the UK possess characteristic clonal features, but are becoming more diverse than other international ST131 populations.
INTRODUCTION
The extra-intestinal pathogenic Escherichia coli (ExPEC) clone ST131-O25b has been frequently isolated from urinary tract (UTI) and bloodstream infections worldwide (NicolasChanoine et al., 2008; Doumith et al., 2015) . In the last decade this clone has been extensively characterized, especially the fluoroquinolone-and cefotaxime-resistant subclade producing CTX-M-15 extended-spectrum beta-lactamase (ESBL) (Nicolas-Chanoine et al., 2008; Lau et al., 2008) .
ST131 strains predominantly express serogroup O25b, although recently CTX-M-producing isolates have been reported within serogroup O16 (Matsumura et al., 2012; Blanc et al., 2014) . The genes encoding CTX-M enzymes (bla CTX-M ) are frequently located on IncF and IncI1 incompatibility group plasmids, often in conjunction with other beta-lactamase genes (bla TEM , bla SHV , bla OXA ) and the aac(69)-Ib-cr gene, which encodes aminoglycoside and quinolone resistance (Matsumura et al., 2012; Carattoli, 2009; Calhau et al., 2013) . This adds to the cumulative resistance burden posed by this clone and its detrimental impact on empirical antibiotic therapy.
Heightened virulence is also considered a defining property of this clone. Attempts to define the virulence repertoire of ST131-O25b identified fimH, fyuA, iutA, traT, malX and the pathogenicity islands CFT073 I, CFT073 II and 536 IV to be carried by w70 % of isolates (Calhau et al., 2013; Clark et al., 2012) . Sequencing of the type I fimbrial adhesin, fimH, has also identified specific alleles associated with multidrug-resistant ST131 strains, namely H30, H22, H35 and H41. The H30 allele in particular was recently shown to be the dominant variant among fluoroquinolone-resistant, CTX-M-15-producing isolates, giving rise to the H30-Rx subclone Johnson et al., 2013; Petty et al., 2014) . Dahbi et al. (2013) have highlighted the lack of European articles on the epidemiology of ST131 isolates, particularly non-O25b ST131 strains. Therefore, we sought to define the true burden of E. coli ST131 infections in the UK, to determine the antibiotic resistance attributed to them and to further characterize this clone and the clonal complex.
METHODS
Isolates. Five hundred and fifty-six (508 urinary and 48 bloodstream) E. coli isolates were collected at the Royal London Hospital between October 2011 and March 2012. Another 519 bloodstream E. coli isolates were collected as part of the British Society for Antimicrobial Chemotherapy (BSAC) Bacteraemia Resistance Surveillance Programme , from 38 centres located across the UK and Republic of Ireland, between January and December 2011 (http://www.bsacsurv.org/).
Identification of ST131 isolates. Isolates were assigned to major E. coli phylogroups by PCR (Doumith et al., 2012) . All phylogroup B2 isolates were screened for an ST131 clonal complex marker and these results confirmed by the detection of clonespecific ST131 pabB SNPs (Clermont et al., 2009) . All ST131/B2 isolates were subjected to fimH sequencing and conventional serogrouping, with serogroup O25 isolates investigated for the O25b antigen by PCR Gross & Rowe, 1985; Clermont et al., 2008) . All ST131 isolates were analysed by PFGE, according to the method of Turton et al. (2004) , for genetic relatedness.
Antibiotic resistance. MICs were determined specifically for this study using the BSAC methodology published previously (BSAC, 2011; Ciesielczuk et al., 2015) and EUCAST breakpoints (www.eucast.org/clinical_breakpoints; version 2.0, 2012). Both urinary (32 mg ml 21 ) and systemic (8 mg ml 21 ) breakpoints were used for 
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temocillin. ST131 isolates that demonstrated resistance to one or more cephalosporins were screened by PCR for genes encoding TEM, OXA, SHV and CTX-M enzymes (Dallenne et al., 2010) . PCR amplicons were sequenced to identify the specific allele. All CTX-Mpositive isolates underwent plasmid-based replicon typing (Carattoli et al., 2005) .
Virulence factors. Random sampling in Microsoft Excel selected 14 ST131 isolates, which were screened for multiple E. coli virulence factors as described previously . In addition, PCR was used to screen for the following pathogenicity islands using published methods: CFT073 I, CFT073 II, J96 I, J96 II and 536 I to IV (Sabaté et al., 2006) .
RESULTS

Isolates
Of the 1075 E. coli isolates studied, 689 (64 %) belonged to phylogroup B2 and 143/689 (21 %) to the ST131 clonal complex. The 143 ST131 isolates comprised 38/508 (7 %) of those from urine samples and 105/567 (19 %) of those from blood cultures, of which 71 and 57 %, respectively, were from community-associated infections. ST131 isolates submitted to the BSAC Bacteraemia Resistance Surveillance Programme were scattered throughout the UK, with a greater proportion of (Table 1) , ST131 was most prevalent in the South West (25 %) and, of all the countries comprising the UK, Wales (37 %).
The majority of ST131 isolates (123/143, 86 %) were of serogroup O25b, followed by O16 (n512), plus single representatives of O19a, O25a, O136 and O153. Four isolates were non-typable. However, only the O25b, O19a, O136 and O153 isolates (n5126) possessed the ST131 clone-specific SNPs in pabB and from here on these are referred to as 'clonal' isolates.
Antibiotic resistance
All clonal isolates (126/143, 88 %) demonstrated high rates of resistance to ampicillin (87 %), ciprofloxacin (79 %), temocillin (bloodstream isolates only, 69 %), gentamicin (67 %), trimethoprim-sulfamethoxazole (59 %) and amoxicillin-clavulanate (56 %). Thirty-two per cent were resistant to at least one third-generation cephalosporin, suggestive of ESBL expression (Fig. 1) . The dominant resistance profile in 27/39 (69 %) CTX-M-positive isolates was AMP/AUG/CTX/CIP/MIN/SXT, while the most common resistance profile in 50/87 (57 %) CTX-M-negative isolates was AMP/CIP/MIN (see Fig. 1 ). All 39/126 (31 %) CTX-M-positive clonal isolates (39/39 O25b-positive) were ciprofloxacin-resistant.
The ESBL genes detected encoded CTX-M-15 (n534), CTX-M-27 (n53) and CTX-M-14 (n52). In addition, 30/39 encoded OXA-1 and 16/39 encoded TEM-1 (13 encoded both). SHV was not detected in any isolate. Further analysis 2 . Distribution of fimH alleles according to ciprofloxacin susceptibility in 126 UK clonal ST131 isolates. Ciprofloxacinresistant isolates contained alleles H30 (n592, spotted) or H22 (n51, diagonal lines) or were negative for fimH (n55, white). Ciprofloxacin-susceptible isolates contained alleles H30 (n58), H27 (n51, black), H22 (n55) or the WT allele (n52, vertical lines) or were negative for fimH (n512). Table 2 .
The 87 CTX-M-negative clonal isolates included 59 (68 %) that were ciprofloxacin-resistant (O25b and O136), and only one isolate (O25b) encoded OXA-1. Neither bla TEM nor bla SHV genes were detected in the CTX-M-negative isolates. 
Virulence factors and genetic relatedness
One hundred and nine clonal isolates (87 %) possessed the fimH gene. By far the most common fimH allele was H30 (n5100, 92 %); the majority of these isolates were ciprofloxacin-resistant (n592/100). All three of the novel serogroups also expressed the H30 allele. H22 was detected in 5 % of the clonal isolates, more frequently in those that were ciprofloxacin-susceptible, H27 was detected in one isolate and two isolates encoded the WT fimH gene (Fig. 2) .
Screening of 14 ST131 isolates (including O25a, O25b and O136) revealed differences in virulence profiles (Table 3) . The most prevalent combination of virulence factors was iutA, iha, traT and usp; identified in 10/14 (71 %) isolates. In addition, 8/14 (57 %) strains encoded the pathogenicity islands CFT073 I, CFT073 II and 536 IV. There was no variation in virulence repertoire according to serogroup, with the exception of pks, which was detected in the O25a isolate only. As in a recent Spanish study (Blanco et al., 2013) , virotype C (afa + iroN 2 ibeA 2 sat + ) was frequently detected (n56/14, 43 %) in the UK isolates.
Typing of the ST131 clonal isolates (n5126) by PFGE revealed j40 % DNA relatedness, yet the new serogroups and isolates with the H27 fimH allele remained closely related (w70 %) to ST131-O25b-H30 strains (Fig. 3) . This suggests that these new characteristics are true features of the ST131 population prevalent within the UK.
DISCUSSION
Since the ST131-O25b pandemic first began in the early 2000s, this clone has been subdivided on the basis of fluoroquinolone resistance, CTX-M production and, more recently, fimH alleles . Recent years have also seen the emergence of ST131-O16 strains (Matsumura et al., 2012; Doumith et al., 2015) . In light of these new findings we evaluated a collection of ST131 strains referred from around the UK.
In our study ST131 strains were more prevalent in community-associated bloodstream infections (n5105, 19 %) than in UTIs (n538, 7 %). This contrasts with a previous UK study in 2008 (Lau et al., 2008 and a more recent one in Spain (Blanco et al., 2013) , in which ST131 was more frequently associated with UTIs and nosocomial infections. However, a shift in ST131 towards community infections and the emergence of another sequence type (ST73) in UTIs within the UK was recently reported (Gibreel et al., 2012) . It is possible that this propensity towards bacteraemia isolates can explain the high rates of antibiotic resistance in this study, along with the plasmids and virulence factors possessed by this clone.
ST131 strains have repeatedly been associated with a single serogroup, O25b. Here we identified the recently described serogroup O16, but also three serogroups novel to this clone; O19a, O136 and O153. However, our ST131-O16 isolates lacked the pabB SNPs specific to this clone and likely represent single-locus variants of ST131 within the larger clonal complex, which have been detected here where other molecular assays have failed to do so . By contrast the novel serogroups may have emerged by high-frequency recombination with other E. coli pathotypes, such as uropathogenic, enteroinvasive, enterotoxigenic or enteroaggregative E. coli (Croxen et al., 2013; Ananias & Yano, 2008) , highlighting the evolutionary capacity of this particular clone.
All of the ST131 strains demonstrated high rates of resistance, accounting for 68 % of the third-generation cephalosporin-resistant isolates and 58 % of ciprofloxacinresistant isolates in the larger study collection (n51075). The resistance rates and ESBL prevalence were similar to those seen in recent UK studies (Gibreel et al., 2012; Horner et al., 2014) , except for fluoroquinolone and aminoglycoside resistance rates, which were much higher. This is likely due to the increased circulation of aac(69)-Ib-cr in ST131 isolates in recent years (Calhau et al., 2013; Blanco et al., 2013) and the co-resistance associated with CTX-M-15 enzymes compared with other CTX-M type enzymes, such as CTX-M-27 (Blanc et al., 2014) . Temocillin resistance has also increased within this clone in the last 10 years (Livermore et al., 2006) , likely a result of increased circulation of ESBLs and the multidrug-resistance plasmids on which they are located and their presence in strains with decreased outer membrane permeability.
The majority of the bla CTX-M genes detected here were carried on IncF plasmids. While this observation is not new, we believe this is the first report of IncU plasmids carried by UK ST131 strains. Typically described in multidrugresistant Aeromonas species, often encoding the quinolone protection protein QnrS (Cattoir et al., 2008) , IncU plasmids have recently been found in ST131-O16 strains in Japan (Matsumura et al., 2013) . However, the IncU plasmids in our collection were identified in ST131-O25b clonal strains.
For the most part, ST131 strains possess a core set of virulence factors ( fimH, fyuA, iutA, traT and malX) and pathogenicity islands (CFT073 I, CFT073 II and 536 IV), with the occasional regional variation (Calhau et al., 2013; Clark et al., 2012) . In this study, these core virulence determinants were detected in 71 % (n510/14) of isolates screened, along with usp (n513, 93 %), iha (n512, 86 %) and kpsMTII (n510, 71 %). Of note, UK ST131 strains appear to have recently acquired kpsMTII (Table 3) , suggesting they have evolved differently to other international ST131 lineages, while attenuating virulence. This hypothesis is supported by a recent Spanish ST131 collection, which was subdivided into four virotypes (A-D) based on the presence of afa, iroN, ibeA and sat. While virotypes C and B were prevalent in Spain (Blanco et al., 2013) , virotype B was absent in the UK collection.
Sequencing of the fimH gene also revealed new insights. All ST131-O16 strains, which were considered non-clonal, possessed a WT fimH allele rather than the H41 allele identified in previous studies. This supports the view that these ST131-O16 strains should be considered separately from other clonal ST131 strains, but are part of the larger clonal complex (Blanc et al., 2014; Petty et al., 2014) . In addition, the H30 allele was prevalent among ESBL-positive and ciprofloxacin-resistant isolates, but also among ciprofloxacin-susceptible isolates, along with the H22 allele. Interestingly, the H27 allele which is dominant in ST95 was identified in one ST131-O25b strain.
PFGE was employed in this study to understand how these strains and novel characteristics (e.g. serogroup O19a) may be related. However, only 40 % DNA similarity was found to link all ST131 strains in this study, with random distribution of CTX-M genes, serogroups and fimH alleles among the clonal complex. This is in contrast to previous studies reporting w60 % genetic relatedness (NicolasChanoine et al., 2008; Doumith et al., 2012) . However, Johnson et al. (2012) also demonstrated great genetic diversity among ST131 strains, suggesting that ST131 pulsotypes are temporally and geographically niche-adapted, as opposed to universally related. It is clear that UK ST131 isolates differ genetically somewhat from international ST131 populations, likely a result of multiple acquisitions of genetic elements and recombination occurring within the accessory genome of this clone (Price et al., 2013; Petty et al., 2014) .
Acquisition of fimH genes, serogroups and plasmids from other E. coli pathotypes and bacterial species clearly signifies the promiscuous nature of ST131 strains and their ability to adapt and evolve for survival. UK ST131 strains are becoming more diverse than those reported in previous studies, suggesting that UK isolates are an expansion of the originally defined ST131-O25b clone. This has implications for strategies aimed at improving surveillance, detection and control of this important multidrug-resistant pathogen.
